Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials-Reference-Cited by-同舟云学术

Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials

Published:2015-11-25 Issue: Volume: Page:h5203
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Storebø Ole Jakob,Krogh Helle B,Ramstad Erica,Moreira-Maia Carlos R,Holmskov Mathilde,Skoog Maria,Nilausen Trine Danvad,Magnusson Frederik L,Zwi Morris,Gillies Donna,Rosendal Susanne,Groth Camilla,Rasmussen Kirsten Buch,Gauci Dorothy,Kirubakaran Richard,Forsbøl Bente,Simonsen Erik,Gluud Christian

Publisher

BMJ

Subject

General Engineering

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should methylphenidate be included in the WHO model lists of essential medicines?;European Child & Adolescent Psychiatry;2024-09-12

2. Effects of methylphenidate on mitochondrial dynamics and bioenergetics in the prefrontal cortex of juvenile rats are sex-dependent;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

3. The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews;Current Behavioral Neuroscience Reports;2024-06-10

4. Plasma fatty acids and attention deficit hyperactivity disorder: a Mendelian randomization investigation;Frontiers in Psychiatry;2024-05-03

5. Efficacy of methylphenidate treatment in childhood myotonic dystrophy type 1 and comorbid attention deficit hyperactivity disorder: A case report using eye tracking assessment;Brain and Development;2024-02